Prevalence of telomerase in coronary artery atherosclerosis

Journal of Anti-Aging Medicine

Volumn 3, Issue 1, 2000, Pages 15-24

  Gupta, Madhu ^a   Shogreen, Marie R ^a   Braden, Gregory A ^a   White, Wain L ^a   Sane, David C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; ATHERECTOMY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RESTENOSIS;

EID: 0034090882     PISSN: 10945458     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.1.2000.3.15     Document Type: Article

References (64)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
2. Schwartz SM, de Blois D, O'Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res 1995;77:445-465.
3. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973;70:1753-1756.
4. Murry CE, Gipaya CT. Bartosek T, et al. Monoclonality of smooth muscle cells in human atherosclerosis. Am J Pathol 1997;151:697-705.
5. Schwartz SM, Murry CE. Proliferation and the monoclonal origins of atherosclerotic lesions. Ann Rev Med 1998;49:437-460.
6. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12:616-623.
7. Serruys PW, Beatl LK, Geuskens BR, et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3 and 4 months. Circulation 1988;77:361-371.
8. Hayflick L, Moorhead P. The serial cultivation of human diploid strains. Exp Cell Res 1961;25:585-621.
9. Greider CW, Blackburn EH. Telomeres, telomerase cancer. Scientific Am 1996;274:92-97.
10. Moyzis RK, Buckingham JM, Cram LS, et al. A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988;85:6622-6626.
11. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-573.
12. Watson JD. Origin of concatemeric T7 DNA. Nature New Biol 1972;239:197-201.
13. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margins in enzymatic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973;41:181-190.
14. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405-413.
15. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995;87:884-894.
16. Morin GB. The implications of telomerase biochemistry for human disease. Eur J Cancer 1997;33:750-760.
17. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 1995;269: 1236-1241.
18. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997;277:955-959.
19. Myerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene is up-regulated in tumor cells and during immortalization. Cell 1997;90:785-795.
20. Weinrich SL, Pruzan R, Ma L, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein component hTRT. Nature Genet 1997;17:498-502.
21. Kim NW, Piatyzek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
22. Langford LA, Piatyszek MA, Xu R, et al. Telomerase activity in human brain tumors. Lancet 1995;364: 1267-1268.
23. Hiyama E, Hiyama K, Yokoyama T, et al. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1995;1:249-255.
24. Harle-Bachor C, Boukamba P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996; 93:6476-6481.
25. Nakayama J, Tahara H, Tahara E, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinoma. Nature Genet 1998;18:65-68.
26. Avilion AA, Piatyszek MA, Gupta J, et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996;56: 645-650.
27. Bryan TM, Reddel RR. Telomerase dynamics and telomerase activity in in vitro immortalized human cells. Eur J Cancer 1997;33:766-773.
28. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996;8:66-71.
29. Piatyszek MA, Kim NW, Weinrich SL, et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol. Methods Cell Sci 1995;17:1-15.
30. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-3715.
31. Chiu CP, Dragowska W, Kim NW, et al. Differential expression of telomerase activity in hematopoietic progenitors from adult bone marrow. Stem Cells 1996;14:239-248.
32. Zhang W, Piatyszek MA, Kobayashi T, et al. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 1996;2:799-803.
33. Bestilny LJ, Brown CB, Miura Y, et al. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res 1996;56:3796-3802.
34. Vaziri H, Benchinvol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998;8:279-282.
35. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life span by introduction of telomerase into normal human cells. Science 1998;279:349-352.
36. World Medical Association of Helsinki. Recommendation guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997;35:2-3.
37. Bryan TM, Englezou A, Gupta J, et al. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995;14:4240-4248.
38. Bennett MR, MacDonald K, Chan S-W, et al. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular muscle cells from atherosclerotic plaques. Circ Res 1998;82:704-712.
39. Bennett MR, Littlewood TD, Schwartz SM, et al. Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaque to p53-mediated apoptosis. Circ Res 1997;81:591-599.
40. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995;95:2266-2274.
41. Mosse PR, Campbell GR, Wang ZL, et al. Smooth muscle phenotypic expression in human carotid arteries, I: comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab Invest 1985;53:556-562.
42. Ross R, Wright T, Strandness E, et al. Human atherosclerosis, I: cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol 1984;114:79-93.
43. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991;196:33-39.
44. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 1995;92:11190-11194.
45. Engelhardt M, Kumar R, Albanell J, et al. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 1997;90:182-193.
46. Counter CM, Botelho FM, Wang P, et al. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994;68:3410-3414.
47. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-1929.
48. Filatov L, Golubovskaya V, Hurt JC, et al. Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein. Oncogene 1998;16:1825-1838.
49. Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996;335:624-630.
50. Speir E, Modali R, Huang ES, et al. Potential role of human cy tomegalovirus and p53 in coronary restenosis. Science 1994;265:391-394.
51. Yamada O, Motoji T, Mizoguchi H. Up-regulation of telomerase activity in human lymphocytes. Biochimica et Biophysica Acta 1996;1314:260-266.
52. Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996;183:2471-2479.
53. Ross R. Atherosclerosis-anti-inflammatory disease. N Engl J Med 1999;340:116-126.
54. Serrano CV Jr, Ramirez JA, Venturinelli M, Arie S, D'Amico E, Zweier JL, Pileggi F, da Luz PL. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory response in coronary angioplasty. J Am Coll Cardiol 1997;29:1276-1283.
55. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-230.
56. Hsiao R, Sharma HW, Ramakrishnan S, Keith E, Narayanan R. Telomerase activity in normal endothelial cells. Anticancer Res 1997;17:827-832.
57. Kumamoto M, Nakashima Y, Sueishi K. Intimal neovasculature in human coronary atherosclerosis: its origin and pathological significance. Hum Pathol 1995;26:450-456.
58. Isner JM, Kearney M, Bortman S, et al. Apoptosis in human atherosclerosis and restenosis. Circulation 1995;91:2703-2711.
59. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995;95:2266-2274.
60. Mandal M, Kumar R. Bcl-2 modulates telomerase activity. J Biol Chem 1997;272:14183-14187.
61. Bennett MR, Evan GI, Schwartz SM. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ Res 1995;77:266-273.
62. Parkinson EK. Do telomerase antagonists represent a novel anti-cancer strategy? Br J Cancer 1996;73:1-4.
63. Morin GB. Is telomerase a universal cancer target? J Natl Cancer Inst 1995;87:859-861.
64. Mata JE, Joshi SS, Palen B, et al. A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicol Applied Pharmacol 1997;144:189-197.